GIBCO® AIM V® Medium CTS™ (Therapeutic Grade) is the first commercially available defined, serum-free formulation for proliferation and⁄or manipulation of T cells and dendritic cells and manufactured in compliance with cGMP. AIM V® Medium CTS™ is an FDA 510(k) cleared device which is intended for human ex-vivo tissue & cell culture processing applications. It contains L-glutamine, 50 µg⁄ml streptomycin sulfate, and 10 µg⁄ml gentamicin sulfate.